PETX News and Press, Aratana Therapeutics Inc. From 04/26/19

Aratana Therapeutics (NASDAQ: PETX ) +37%  on Elanco takeover . More news on: Aratana Therapeutics, Inc., Regional Health Properties, Inc., Reebonz Holding Limited, Stocks on the move, Read more ...

Elanco Animal Health (NYSE: ELAN ) has agreed to acquire Aratana Therapeutics (NASDAQ: PETX ), a developer of treatments for dogs and cats, for an undisclosed sum. More news on: Elanco Animal Health Incorporated, Aratana Therapeutics, Inc., Healthcare stocks news, Merger & acquisitio...

Elanco announces investor call for 9:00 am today Elanco Animal Health (NYSE:ELAN) today announced it has signed an agreement to acquire Aratana Therapeutics (NASDAQ:PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, a...

LEAWOOD, Kan. , April 26, 2019 /PRNewswire/ -- Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, announced it has signed an agreement to be acquired by Elanco Animal Health (NYSE: ELAN)...

LEAWOOD, Kan. , April 22, 2019 /PRNewswire/ -- Aratana Therapeutics, Inc. (Nasdaq: PETX), a pet therapeutics company focused on the development and commercialization of innovative therapeutics for dogs and cats, will host a live conference call on Wednesday, May 8 at 4:30 p.m. ET to d...

Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years, including nearly 100 weeks of public selections as part of this ongoing live forward-testing. In 2017, the sample size began with 12 stocks, then 8 stocks ...

The following slide deck was published by Aratana Therapeutics, Inc. in conjunction with this Read more ...

The following slide deck was published by Aratana Therapeutics, Inc. in conjunction with this Read more ...

Aratana Therapeutics, Inc. (PETX) Q4 2018 Earnings Conference Call March 12, 2019 04:30 PM ET Company Participants Rachel Reiff - Corporate Communications Craig Tooman - President & CEO Rhonda Hellums - CFO Ernst Heinen - Chief Development Officer Chris Ready - VP of Sale...

Aratana Therapeutics (NASDAQ: PETX ): Q4 GAAP EPS of -$0.18. More news on: Aratana Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...